EGFR blockade enriches for lung cancer stem-like cells through Notch3-dependent signaling.
about
The role of epithelial to mesenchymal transition in resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancerTargeting Notch to overcome radiation resistanceAdvances in Lung Stem Cells and Lung Cancer Stem CellsDeciphering Crosstalk Circuits in Non-small Cell Lung Cancers with an Increasing Interval Length of Low Dose CT ScreeningEpidermal growth factor receptor and notch signaling in non-small-cell lung cancerTriptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling.Notch signaling and EMT in non-small cell lung cancer: biological significance and therapeutic application.Randomized Adjuvant Chemotherapy of EGFR-Mutated Non-Small Cell Lung Cancer Patients with or without Icotinib Consolidation Therapy.Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancerAberrant activation of Notch signaling in extrahepatic cholangiocarcinoma: clinicopathological features and therapeutic potential for cancer stem cell-like propertiesMonitoring cancer stem cells: insights into clinical oncology.Musashi-2 (MSI2) supports TGF-β signaling and inhibits claudins to promote non-small cell lung cancer (NSCLC) metastasis.FGFR1 promotes the stem cell-like phenotype of FGFR1-amplified non-small cell lung cancer cells through the Hedgehog pathway.Notch4+ cancer stem-like cells promote the metastatic and invasive ability of melanoma.Prolyl-isomerase Pin1 controls Notch3 protein expression and regulates T-ALL progression.Short-term EGFR blockade enhances immune-mediated cytotoxicity of EGFR mutant lung cancer cells: rationale for combination therapies.A feed-forward loop between lncARSR and YAP activity promotes expansion of renal tumour-initiating cells.Carbon ion irradiation withstands cancer stem cells' migration/invasion process in Head and Neck Squamous Cell Carcinoma (HNSCC).Epigenetic therapy potential of suberoylanilide hydroxamic acid on invasive human non-small cell lung cancer cellsCancer stem cells and tumor-associated macrophages: a roadmap for multitargeting strategies.Antagonism of EGFR and Notch limits resistance to EGFR inhibitors and radiation by decreasing tumor-initiating cell frequency.Notch3 signaling-mediated melanoma-endothelial crosstalk regulates melanoma stem-like cell homeostasis and niche morphogenesis.Inhibition of the cancer stem cells-like properties by arsenic trioxide, involved in the attenuation of endogenous transforming growth factor beta signal.Concise Review: Emerging Drugs Targeting Epithelial Cancer Stem-Like Cells.Activation of signal transducer and activator of transcription 3 (STAT3) signaling in EGFR mutant non-small-cell lung cancer (NSCLC)Inhibition of Hes1 enhances lapatinib sensitivity in gastric cancer sphere-forming cells.Sulforaphane reverses gefitinib tolerance in human lung cancer cells via modulation of sonic hedgehog signaling.LncRNAs and their role in cancer stem cells.Combined Erlotinib and PF-03084014 treatment contributes to synthetic lethality in head and neck squamous cell carcinoma.Prospects for new lung cancer treatments that target EMT signaling.Evaluation of role of Notch3 signaling pathway in human lung cancer cells.NOTCH3 inactivation increases triple negative breast cancer sensitivity to gefitinib by promoting EGFR tyrosine dephosphorylation and its intracellular arrest.NOTCH3 binds activated EGFREGFR phosphorylates NOTCH3NOTCH3 Activation and Transmission of Signal to the NucleusNotch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC
P2860
Q26749110-A64AD028-1E7B-40AE-8368-F1F8A7456657Q26771701-380191C9-CB9C-42B9-9DC6-C880608B3132Q26781688-3429F935-ACFE-4A5A-8D4F-10BB002B101DQ26783155-24C9EA9B-909E-4559-968B-067978A9F698Q28080187-BBE9C21E-3888-4119-9004-9E7E79F77EE2Q33688875-EC97296F-C326-4DDB-96B0-9BCD4A2CEE0AQ34712645-2A060D50-8812-4535-A744-27808187C651Q35810510-B9746BFA-2671-4B6A-ACB1-D4C83DA370C9Q36022297-0113852F-E609-4FA2-8680-C070D2BEC4AFQ36184732-DA1B09FE-8D06-4116-8233-767C31D7FCDFQ36585140-19DF106D-04FC-45F6-8D74-4441894F7F0CQ37040720-9DE47400-F55B-4897-ACF8-C4D3765CCD6DQ37046814-F32793FF-C236-4552-BF9F-D7DF99D210B8Q37170715-AB0BC238-BC54-4634-BB92-932E736A9152Q37257716-04AC0060-D865-40B5-A8C3-11EC22252DF0Q37330932-D8B4AB8C-5898-40A7-847F-7D5F34C27C4AQ37464844-63C406D8-9012-421E-A8E5-91C05C47CABFQ37565255-6DFF34EA-02BB-441F-AD32-498FAF8ED9E5Q37708851-1CC68432-E8AC-4DB5-B0FC-3F51DDD73F0BQ38472322-2694F3FC-AC56-4857-A458-23B4BD3BD08AQ38713045-BC5FBA20-40C8-43D7-9472-59DDC1FE7DC8Q38717772-C43CDF93-F013-4F7A-9596-28B02146F25FQ38949050-A7B54E18-25BE-4614-BC91-054D69962ECFQ39112034-C7331748-E74E-42F8-B0E5-EA033AE27032Q41471047-52ADF4D5-5FF7-4919-9351-C199DCB6DB54Q41676850-8AB463D0-53BF-4BF4-A72D-2A90FAE7896DQ47097913-E417EDB3-A08B-4C7E-B02B-9CDB8A333871Q47116275-C0366DF6-138C-4FF9-8BAD-A892DA0BC03EQ48132559-6839E4A3-001D-4C78-B23B-338AD1901CBFQ48271468-A94D960A-0E62-4EC0-BE29-D31C687DA213Q52886289-18A05C3E-F5FF-4E50-9DA2-E06CC96FE6B1Q54978331-A4B8AF25-1503-4F8A-999A-3728CCBA3A57Q55219500-85436BA7-B742-48C4-9DAB-BAC832FEF5A9Q55219504-CA839933-13E3-42FB-9F30-7DFE5AB18FC0Q55230906-E9C61845-6C29-4CE4-BB2E-01758604E8B9Q58790384-8EBB0B3A-D498-4391-91DD-C067BD42D980
P2860
EGFR blockade enriches for lung cancer stem-like cells through Notch3-dependent signaling.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
EGFR blockade enriches for lun ...... gh Notch3-dependent signaling.
@en
type
label
EGFR blockade enriches for lun ...... gh Notch3-dependent signaling.
@en
prefLabel
EGFR blockade enriches for lun ...... gh Notch3-dependent signaling.
@en
P2093
P2860
P1433
P1476
EGFR blockade enriches for lun ...... gh Notch3-dependent signaling.
@en
P2093
David P Carbone
Joseph M Amann
Mohammad A Rahman
Rajeswara Rao Arasada
Stacey S Huppert
P2860
P304
P356
10.1158/0008-5472.CAN-13-3724
P407
P577
2014-08-14T00:00:00Z